SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-004911
Filing Date
2013-04-26
Accepted
2013-04-26 06:07:56
Documents
6
Period of Report
2013-06-07
Effectiveness Date
2013-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214324zdef14a.htm DEF 14A 371068
2 G247908.JPG g247908.jpg GRAPHIC 6143
3 G96682BCI001.GIF g96682bci001.gif GRAPHIC 107554
4 G96682BCI002.GIF g96682bci002.gif GRAPHIC 79282
5 G96683BGI001.GIF g96683bgi001.gif GRAPHIC 121884
6 G96683BGI002.GIF g96683bgi002.gif GRAPHIC 92342
  Complete submission text file 0001047469-13-004911.txt   933918
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35890 | Film No.: 13784607
SIC: 2834 Pharmaceutical Preparations